Vecuronium Bromide Related Compound B (Piperidinium, 1-[(2beta, 3alpha, 5alpha, 16beta, 17beta)-3-acetyloxy-17-hydroxy-2-(1-piperidinyl)androstan-16-yl]-1-methyl bromide)
|
|
|
- CAS番号.
- 50587-95-6
- 化学名:
- Vecuronium Bromide Related Compound B (Piperidinium, 1-[(2beta, 3alpha, 5alpha, 16beta, 17beta)-3-acetyloxy-17-hydroxy-2-(1-piperidinyl)androstan-16-yl]-1-methyl bromide)
- 别名:
- Vecuronium Bromide Related Compound B (Piperidinium, 1-[(2beta, 3alpha, 5alpha, 16beta, 17beta)-3-acetyloxy-17-hydroxy-2-(1-piperidinyl)androstan-16-yl]-1-methyl bromide)
- 英語名:
- 17-deacetylvecuronium
- 英語别名:
- 17-deacetylvecuronium;Vecuronium EP Impurity E;Vecuronium bromide impurity B;17-Desacetyl vecuronium bromide;Vecuronium Bromide EP Impurity E;VecuroniuM BroMide Related CoMpound B;Vecuronium bromide related substance B;Vecuronium Bromide Related Compound B (F0G180);Vecuronium Bromide Impurity 5(Vecuronium Bromide EP Impurity E);1-[3α-(acetyloxy)-17β-hydroxy-2β-(piperidin-1-yl)-5α-androstan-16β-yl]-1-methylpiperidin-1-ium
- CBNumber:
- CB51326964
- 化学式:
- C32H55BrN2O3
- 分子量:
- 595.6947
- MOL File:
- 50587-95-6.mol
|
Vecuronium Bromide Related Compound B (Piperidinium, 1-[(2beta, 3alpha, 5alpha, 16beta, 17beta)-3-acetyloxy-17-hydroxy-2-(1-piperidinyl)androstan-16-yl]-1-methyl bromide) 物理性質
安全性情報
- リスクと安全性に関する声明
- 危険有害性情報のコード(GHS)
| 絵表示（GHS） |
 
|
| 注意喚起語 |
危険 |
| 危険有害性情報 |
| コード |
危険有害性情報 |
危険有害性クラス |
区分 |
注意喚起語 |
シンボル |
P コード |
| H301 |
飲み込むと有毒 |
急性毒性、経口 |
3 |
危険 |
|
P264, P270, P301+P310, P321, P330,P405, P501 |
| H371 |
臓器の障害のおそれ |
特定標的臓器有害性、単回暴露 |
2 |
警告 |
|
P260, P264, P270, P309+P311, P405,P501 |
|
| 注意書き |
| P260 |
粉じん/煙/ガス/ミスト/蒸気/スプレーを吸入しないこ と。 |
|
Vecuronium Bromide Related Compound B (Piperidinium, 1-[(2beta, 3alpha, 5alpha, 16beta, 17beta)-3-acetyloxy-17-hydroxy-2-(1-piperidinyl)androstan-16-yl]-1-methyl bromide) 価格
もっと(4)
| メーカー |
製品番号 |
製品説明 |
CAS番号 |
包装 |
価格 |
更新時間 |
購入 |
|
富士フイルム和光純薬株式会社(wako)
|
W01TRCA164495 |
1-[(2β,3α,5α,16β,17β)-3-(Acetyloxy)-17-hydroxy-2-(1-piperidinyl)androstan-16-yl]-1-methylpiperidinium Bromide |
50587-95-6 |
1mg |
￥41300 |
2023-06-01 |
購入 |
|
富士フイルム和光純薬株式会社(wako)
|
W01TRCA164495 |
1-[(2β,3α,5α,16β,17β)-3-(Acetyloxy)-17-hydroxy-2-(1-piperidinyl)androstan-16-yl]-1-methylpiperidinium Bromide |
50587-95-6 |
5mg |
￥172200 |
2023-06-01 |
購入 |
|
富士フイルム和光純薬株式会社(wako)
|
W01USP1711177 |
Vecuronium Bromide Related Compound B (Piperidinium, 1-[(2beta, 3alpha, 5alpha, 16beta, 17beta)-3-acetyloxy-17-hydroxy-2-(1-piperidinyl)androstan-16-yl]-1-methyl bromide)
Vecuronium Bromide Related Compound B (Piperidinium, 1-[(2beta, 3alpha, 5alpha, 16beta, 17beta)-3-acetyloxy-17-hydroxy-2-(1-piperidinyl)androstan-16-yl]-1-methyl bromide) |
50587-95-6 |
15mg |
￥342900 |
2024-03-01 |
購入 |
|
富士フイルム和光純薬株式会社(wako)
|
W01TRCA164495 |
1-[(2β,3α,5α,16β,17β)-3-(Acetyloxy)-17-hydroxy-2-(1-piperidinyl)androstan-16-yl]-1-methylpiperidinium Bromide |
50587-95-6 |
10mg |
￥297000 |
2023-06-01 |
購入 |
Vecuronium Bromide Related Compound B (Piperidinium, 1-[(2beta, 3alpha, 5alpha, 16beta, 17beta)-3-acetyloxy-17-hydroxy-2-(1-piperidinyl)androstan-16-yl]-1-methyl bromide) 化学特性,用途語,生産方法
使用
1-[(2β,3α,5α,16β,17β)-3-(Acetyloxy)-17-hydroxy-2-(1-piperidinyl)androstan-16-yl]-1-methylpiperidinium Bromide, is the metabolite of Vecuronium Bromide (V102500), having neuromuscular and vagal blocking actions.
Vecuronium Bromide Related Compound B (Piperidinium, 1-[(2beta, 3alpha, 5alpha, 16beta, 17beta)-3-acetyloxy-17-hydroxy-2-(1-piperidinyl)androstan-16-yl]-1-methyl bromide) 上流と下流の製品情報
原材料
準備製品
Vecuronium Bromide Related Compound B (Piperidinium, 1-[(2beta, 3alpha, 5alpha, 16beta, 17beta)-3-acetyloxy-17-hydroxy-2-(1-piperidinyl)androstan-16-yl]-1-methyl bromide) 生産企業
Global( 38)Suppliers
50587-95-6(Vecuronium Bromide Related Compound B (Piperidinium, 1-[(2beta, 3alpha, 5alpha, 16beta, 17beta)-3-acetyloxy-17-hydroxy-2-(1-piperidinyl)androstan-16-yl]-1-methyl bromide))キーワード:
- 50587-95-6
- 17-deacetylvecuronium
- 1-[(2β,3α,5α,16β,17β)-3-(Acetyloxy)-17-hydroxy-2-(1-piperidinyl)androstan-16-yl]-1-MethylpiperidiniuM BroMide
- 1-[(2beta,3alpha,5alpha,16beta,17beta)-3-(Acetyloxy)-17-hydroxy-2-(1-piperidinyl)androstan-16-yl]-1-methylpiperidinium bromide
- VecuroniuM BroMide Related CoMpound B
- Vecuronium EP Impurity E
- Vecuronium Bromide Impurity 5(Vecuronium Bromide EP Impurity E)
- Vecuronium bromide related substance B
- Vecuronium Bromide EP Impurity E
- 1-((2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-3-acetoxy-17-hydroxy-10,13-dimethyl-2-(piperidin-1-yl)hexadecahydro-1H-cyclopenta[a]phenanthren-16-yl)-1-methylpiperidin-1-ium bromide
- 17-Desacetyl vecuronium bromide
- Vecuronium Bromide Related Compound B (F0G180)
- 1-[(2β,3α,5α,16β,17β)-3-(Acetyloxy)-17-hydroxy-2-(1-piperidinyl)androstan-16-yl]-1-methylpiperidiniu
- Vecuronium bromide impurity B
- Vecuronium Bromide Related Compound B (Piperidinium, 1-[(2beta, 3alpha, 5alpha, 16beta, 17beta)-3-a (1711177)
- 1-[3α-(Acetyloxy)-17β-hydroxy-2β-(piperidin-1-yl)-5α-androstan-16β-yl]-1-methylpiperidin-1-ium Bromide
- 1-[3α-(acetyloxy)-17β-hydroxy-2β-(piperidin-1-yl)-5α-androstan-16β-yl]-1-methylpiperidin-1-ium
- 1-((2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-3-Acetoxy-17-hydroxy-10,13-dimethyl-2-(piperidin-1-yl)hexadecahydro-1H-cyclopenta[a]phenanthren-16-yl)-1-methylpiperidin-1-ium bromide (Vecuronium Bromide Impurity)
- Vecuronium Bromide Related Compound B (Piperidinium, 1-[(2beta, 3alpha, 5alpha, 16beta, 17beta)-3-acetyloxy-17-hydroxy-2-(1-piperidinyl)androstan-16-yl]-1-methyl bromide)